Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for ...
read more
Thursday, August 03, 2023
Celegence, a regulatory compliance service and software solution company, announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.
read more
Tuesday, February 06, 2024
Celerion, a clinical research organization, announced its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.
read more
Wednesday, April 06, 2022
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing...
read more
Monday, November 11, 2013
Celerion is pleased to announce the appointment of Clayton Dehn as Executive Director, Metabolic Diseases. Mr. Dehn will lead the expansion of Celerion’s current capabilities that support early Proof-of-Concept in the development of diabetes, obesity...
read more
Wednesday, December 11, 2013
Celerion is pleased to announce the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Mr. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
read more
Friday, December 20, 2013
Celerion is proud to announce the 80th anniversary of operations at our first facility in Lincoln, Nebraska. Celerion is at the forefront of early clinical research with corporate headquarters in Lincoln, plus seven other facilities globally ...
read more
Thursday, October 30, 2014
Celerion announces the successful recapitalization of its business through investment by [2]MTS Health Investors, LLC, the New York-based healthcare private equity firm. MTS has partnered with management and will provide capital to support future ...
read more
Friday, February 14, 2020
Nebraska Innovation Campus has announced a new partner. Celerion will move into this space on the campus in February of 2020.
read more
Wednesday, March 09, 2022
Celerion has announced completion of additions to its research capacity and services. This includes the opening of a new Screening and Return Center, upgraded pharmacy compounding suites, expanded Absorption, Distribution, Metabolism and Excretion (...
read more
Celerion announced the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities.
read more
Wednesday, October 31, 2018
Celerion announced the implementation of FibroScan to complement a suite of soluble biomarkers Celerion has validated to support nonalcoholic steatohepatitis (NASH) clinical studies.
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more
Wednesday, February 19, 2025
Celerion announced a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health. This state-of-the-art clinical research center, led by Queen’s University Belfast, in partnership with the Belfast Health and Social Care ...
read more
Wednesday, March 15, 2017
Celerion, a provider of early clinical research solutions, has implemented Verified Clinical Trials (VCT) biometric fingerprint technology to prevent dual enrollment in clinical trials.
read more